SE8702642D0 - Lokalt anvendbara, pharmaceutiska beredningar - Google Patents

Lokalt anvendbara, pharmaceutiska beredningar

Info

Publication number
SE8702642D0
SE8702642D0 SE8702642A SE8702642A SE8702642D0 SE 8702642 D0 SE8702642 D0 SE 8702642D0 SE 8702642 A SE8702642 A SE 8702642A SE 8702642 A SE8702642 A SE 8702642A SE 8702642 D0 SE8702642 D0 SE 8702642D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparations
locally applicable
compositions
dimethyllauroylamide
dodecylazacycloheptan
Prior art date
Application number
SE8702642A
Other languages
English (en)
Other versions
SE8702642L (sv
Inventor
P Frankhauser
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8702642D0 publication Critical patent/SE8702642D0/sv
Publication of SE8702642L publication Critical patent/SE8702642L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8702642A 1986-06-27 1987-06-25 Lokalt anvendbara, farmaceutiska beredningar SE8702642L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2597/86A CH666621A5 (de) 1986-06-27 1986-06-27 Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.

Publications (2)

Publication Number Publication Date
SE8702642D0 true SE8702642D0 (sv) 1987-06-25
SE8702642L SE8702642L (sv) 1987-12-28

Family

ID=4237351

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702642A SE8702642L (sv) 1986-06-27 1987-06-25 Lokalt anvendbara, farmaceutiska beredningar

Country Status (27)

Country Link
US (1) US4999379A (sv)
JP (1) JPS638329A (sv)
KR (1) KR880000093A (sv)
AT (1) AT397199B (sv)
AU (1) AU612323B2 (sv)
BE (1) BE1000233A4 (sv)
CA (1) CA1315692C (sv)
CH (1) CH666621A5 (sv)
DD (1) DD263448A5 (sv)
DE (1) DE3720896A1 (sv)
DK (1) DK326587A (sv)
ES (1) ES2010224A6 (sv)
FI (1) FI872808A (sv)
FR (1) FR2601588B1 (sv)
GB (1) GB2192539B (sv)
GR (1) GR871002B (sv)
HU (1) HU197984B (sv)
IT (1) IT1216827B (sv)
LU (1) LU86929A1 (sv)
MY (1) MY101570A (sv)
NL (1) NL8701508A (sv)
NO (1) NO872685L (sv)
NZ (1) NZ220861A (sv)
PH (1) PH26781A (sv)
PT (1) PT85158B (sv)
SE (1) SE8702642L (sv)
ZA (1) ZA874621B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US4902676A (en) * 1986-09-29 1990-02-20 Nelson Research & Development Co. Compositions comprising N,N-dialkylalkanamides
CA1334646C (en) * 1988-04-08 1995-03-07 James Vanolden Peck Transdermal penetration enhancers
JPH04193826A (ja) * 1990-11-27 1992-07-13 Shirogane Seiyaku Kk ジクロフェナクナトリウム含有の経皮吸収型消炎・鎮痛貼布剤
DE9016291U1 (sv) * 1990-11-30 1991-03-28 Kali-Chemie Pharma Gmbh, 3000 Hannover, De
DK0498011T3 (da) * 1991-02-07 1995-07-03 Heumann Pharma Gmbh & Co Nye salte af 2-(2,6-dichloranilino)-phenyleddikesyre, fremgangsmåde til fremstilling af disse salte og saltenes anvendelse som topisk anvendelse farmaceutiske præparater
WO1993000873A1 (en) * 1991-07-03 1993-01-21 Sano Corporation Composition and method for transdermal delivery of diclofenac
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
WO1996004902A1 (fr) * 1994-08-09 1996-02-22 Tsumura & Co. Composition pour preparation a usage externe
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
KR19990082208A (ko) * 1996-02-07 1999-11-25 오이시 고지 디클로페낙 나트륨의 투명 수용액 및 이를 이용한 의약 조성물
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
JP4854163B2 (ja) * 2000-04-18 2012-01-18 久光製薬株式会社 抗炎症剤含有貼付剤
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
DE102007038413A1 (de) * 2007-08-09 2009-02-12 Beiersdorf Ag Kosmetische Emulgatorkombination
ITMI20111355A1 (it) 2011-07-20 2013-01-21 Epifarma Srl Cerotto transdermico contenente diclofenac e tiocolchicoside
WO2014068600A1 (en) 2012-11-02 2014-05-08 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising diclofenac
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
CH655656B (sv) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
EP0139127A1 (en) * 1983-08-22 1985-05-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Transdermal drug delivery device and its preparation
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
JPS60156080A (ja) * 1984-01-25 1985-08-16 Konishiroku Photo Ind Co Ltd 温度制御手段を備えた複写装置
EP0156080B2 (en) * 1984-03-05 1993-10-20 Nitto Denko Corporation Percutaneous absorption type adhesive pharmaceutical preparation
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤

Also Published As

Publication number Publication date
US4999379A (en) 1991-03-12
AT397199B (de) 1994-02-25
GB2192539A (en) 1988-01-20
FI872808A (fi) 1987-12-28
DD263448A5 (de) 1989-01-04
GB2192539B (en) 1990-10-24
FI872808A0 (fi) 1987-06-24
NZ220861A (en) 1990-08-28
ATA160487A (de) 1993-07-15
BE1000233A4 (fr) 1988-09-20
ZA874621B (en) 1988-02-24
CA1315692C (en) 1993-04-06
LU86929A1 (de) 1988-07-14
IT8748097A0 (it) 1987-06-24
DE3720896A1 (de) 1988-01-14
PH26781A (en) 1992-10-13
FR2601588A1 (fr) 1988-01-22
JPS638329A (ja) 1988-01-14
NO872685L (no) 1987-12-28
NL8701508A (nl) 1988-01-18
PT85158A (en) 1987-07-01
SE8702642L (sv) 1987-12-28
HU197984B (en) 1989-07-28
GR871002B (en) 1987-10-20
ES2010224A6 (es) 1989-11-01
IT1216827B (it) 1990-03-14
PT85158B (pt) 1990-03-30
FR2601588B1 (fr) 1990-06-15
AU612323B2 (en) 1991-07-11
DK326587D0 (da) 1987-06-26
MY101570A (en) 1991-12-17
KR880000093A (ko) 1988-03-23
NO872685D0 (no) 1987-06-26
AU7476287A (en) 1988-01-07
GB8714625D0 (en) 1987-07-29
HUT44180A (en) 1988-02-29
CH666621A5 (de) 1988-08-15
DK326587A (da) 1987-12-28

Similar Documents

Publication Publication Date Title
SE8702642L (sv) Lokalt anvendbara, farmaceutiska beredningar
ATE262329T1 (de) Formulierungen und verfahren zur verminderung der toxizität von anti-neoplastischen mitteln
DK136186A (da) Laegemiddelbaerer
CS553490A3 (en) Transdermal therapeutic system
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
FR2720003B1 (fr) Dispositif servant à inciser la peau pour une médication transcutanée.
DK0413528T3 (da) Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse
ATE162725T1 (de) Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
ES2144054T3 (es) Complejos de tri(platino).
DE69812100D1 (de) Adenosin enthaltendes arzneimittel
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
ES2079687T3 (es) Composicion topica.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702642-3

Effective date: 19950101

NAV Patent application has lapsed

Ref document number: 8702642-3